« Return to News | R&D Trends

MediSapiens, Bayer HealthCare collaborate in oncology

Tuesday, October 11, 2011 01:01 PM

MediSapiens and Bayer HealthCare Pharmaceuticals have agreed to develop a platform for genomics data management and analysis in oncology.

The platform will enable Bayer to more effectively utilize genomics data in oncology research, such utilization to be conducted in compliance with respective patients' informed consent and applicable laws and regulations.

"Genomics data is increasingly used both in pre-clinical and clinical research, but lacks software tools that can be adapted to various research environments. Our flexible platform and know-how in designing software for demanding bioinformatics environments will be tailored to meet the needs of oncology research at Bayer HealthCare Pharmaceuticals,” says Tommi Pisto, CEO of MediSapiens.

"Our core knowledge is to combine bioinformatics and web software. Experience in building and managing the world's largest unified gene expression database for researchers' needs has been invaluable in creating the flexible and scalable genomics platform we now put into use for this project,” adds Sami Kilpinen, PhD, CSO of MediSapiens .

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.